Three of Calibr’s lead scientists—Travis Young, PhD; Arnab Chatterjee, PhD; and Kristen Johnson, PhD—took to the stage in California on June 13, 2019 to discuss efforts to create medicines for some of the most critical and widespread health concerns facing the world.